Definitive Healthcare Corp. (DH) shares plummeted 13.62% in the after-hours trading session on Thursday, following the company's financial results for the fourth quarter and full fiscal year 2024. The healthcare commercial intelligence provider reported a significant net loss due to substantial goodwill impairment charges, along with a weak outlook for the first quarter of 2025.
In the fourth quarter of 2024, Definitive Healthcare recorded a net loss of $84.7 million, or 136% of revenue, largely driven by $97.1 million in goodwill impairment charges. The company's adjusted EBITDA declined to $17.5 million, or 28% of revenue, compared to $19.8 million, or 30% of revenue, in the same period last year.
For the full year 2024, Definitive Healthcare reported a net loss of $591.4 million, or 235% of revenue, including goodwill impairment charges of $688.9 million. While the company's revenue grew marginally to $252.2 million, its adjusted EBITDA margin improved slightly to 31% from 30% in 2023.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。